Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies by Zhong, Xiao-bo et al.
Simultaneous detection of microsatellite repeats
and SNPs in the macrophage migration inhibitory
factor (MIF) gene by thin-film biosensor chips
and application to rural field studies
Xiao-bo Zhong
1, Lin Leng
2, Anna Beitin
3, Rui Chen
1,4, Courtney McDonald
2, Betty Hsiao
2,
Robert D. Jenison
6, Insoo Kang
2, Sung-Hwan Park
7, Annette Lee
8, Peter Gregersen
8,
Philip Thuma
9,10, Patricia Bray-Ward
1, David C. Ward
1 and Richard Bucala
2,5,*
1Department of Genetics,
2Department of Medicine,
3Department of Epidemiology and Public Health,
4Department
of Molecular, Cellular and Developmental Biology,
5Department of Pathology, Yale University School of Medicine,
333 Cedar Street, New Haven, CT 06510, USA,
6Thermo Electron, Corp., Clinical Chemistry Division, Louisville,
CO 80027, USA,
7Department of Internal Medicine, Kangnam St Mary’s Hospital, The Catholic University of Korea,
Seoul, Korea,
8North Shore-LIJ Research Institute, Manhasset, NY, USA,
9Macha Malaria Research Institute,
Choma, Zambia and
10Macha Malaria Research Institute, Dillsburg, PA, USA
Received June 8, 2005; Revised and Accepted July 14, 2005
ABSTRACT
Microsatellite repeat and single nucleotide poly-
morphisms (SNPs) are abundant sources of genetic
variation, but existing methodologies cannot
simultaneously detect these variants in a facile or
inexpensive way. We describe herein a thin-film
biosensor chip based on an allele-discriminating
oligonucleotide array that enables genotyping for
both microsatellite repeats and SNPs in a single anal-
ysis. We validated this methodology for the function-
ally polymorphic  794 CATT5–8 repeat and  173 G/C
SNP present in the promoter of the human gene for
macrophage migration inhibitory factor (MIF). In a
comparisonof30samplescollectedataruralhospital
in Zambia, we observeda100% concordance forboth
the CATT repeat and G/C SNP between the biosensor
methodology and the conventional capillary electro-
phoresis. The biosensor chips are low in cost and
once printed, they are robust and require no instru-
mentation for analysis. When combined with multiple
displacement amplification, this methodology can
be utilized in primitive settings for the genotyping
of nanogram quantities of DNA present in blood,
dried and stored on filter paper samples. We applied
this methodology to a field study of MIF genotype in
children with malaria, and provide first evidence for
a potential association between MIF alleles and
malaria infection. We also present data supporting
significantpopulationstratificationofthelow-versus
high-expressionformsofMIFthatmaybearontherole
of this gene in infectious diseases.
INTRODUCTION
Emerging knowledge about the association of the variant alle-
les of different genes with the human diseases has focused
attention on the development of technologies to rapidly
discriminate between different genotypes (1). New methods
are important, both to facilitate the acquisition of genotyping
data and to better translate this knowledge into diagnostic
and therapeutic applications. Studies of the genetics of
host immunity, for example, are revealing novel pathogenic
mechanisms that are important for understanding infectious
diseases as they affect different human populations (2,3).
Rapid and low-cost genotyping methods are especially
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doi:10.1093/nar/gni123important for studies in the developing world, where the facili-
ties for DNA analysis are limited and where the timely, on-site
utilization of genetic information could make an impact on
morbidity and mortality.
Our studies of polymorphisms in the gene for the cytokine,
macrophage migration inhibitory factor (MIF), and its role in
malaria infection has prompted us to develop a robust geno-
typing method that can be performed on-site, in rural ﬁeld
settings, and at low-cost and turnaround time. MIF plays an
important rolein the innateand the adaptive immune response,
and it is encoded by a functionally polymorphic gene that has
been linked to the incidence or the severity of different inﬂam-
matory conditions (4,5). These MIF alleles differ in the struc-
ture of their promoter region, which varies by the presence of a
tetranucleotide, CATT, that is repeated between 5 and 8 times
in the promoter ( 794 CATT5–8) (6). This repeat regulates
basal and stimulus-induced transcriptional activity, which
increases almost proportionally with repeat number in deﬁned
in vitro assay systems. A single nucleotide polymorphism
(SNP) ( 173 G/C) in the MIF promoter may also inﬂuence
promoter activity, either by linkage disequilibrium or by an
interaction with the tetranucleotide site (7–9).
The close interplay between the genes of the immune
system and the host response to infection has led us to inves-
tigate the distribution of variant MIF alleles in populations, in
which different infectious diseases are endemic, with the aim
of better understanding the role of selective pressures on the
evolution of the MIF locus. Toward this end, we have devel-
oped and implemented a thin-ﬁlm optical biosensor chip for
genotyping of both tetranucleotide CATT repeats and SNPs
in a single analysis that greatly facilitates the examination of
small quantities of DNA obtained in the ﬁeld. These chips are
based on an allele-discriminating oligonucleotide array that
provides a direct visual readout of the different MIF promoter
polymorphisms. We document, herein, the application of this
technology to the analysis of MIF gene polymorphisms in
dried blood spots collected in a rural hospital where malaria
is endemic.
METHODS
Patient samples
DNA specimens from normal controls of known MIF
genotype were used to develop the biosensor methodology.
Validation was performed on a random selection of DNA
specimens culled from ongoing studies of MIF genotype,
and included Caucasians, African-Americans, North East
Asians (Koreans) and the African sub-groups described in
the text. The African sub-group specimens were collected
either by K. K. Kidd and J. R. Kidd, or by one of their col-
laborators as part of their long-term studies on human genetic
diversity. The malaria-infected samples were obtained as part
of investigations at the Macha Mission Hospital in Choma,
Zambia, which is holoendemic for Plasmodium falciparum
malaria. These specimens consisted of blood samples that
had been spotted on ﬁlter paper, dried and stored for several
months. Parasitemia was assessed on hospital admission
by enumeration of infected red cells in thick blood smears.
All samples were obtained and utilized in accordance
with institutional and local IRB protocols. The SAS statistical
software package was used to perform c
2 analysis and
logistic regression to determine the relationship between
parasitemia and MIF genotype.
DNA extraction
Genomic DNA was isolated from patient blood or from
the blood spots dried on ﬁlter papers using the QIAamp
DNA Blood Mini kit (Qiagen, Valencia, CA) and the recom-
mended protocols provided by the manufacturer.
DNA amplification by multiple displacement
amplification
DNA extracted from blood spots dried on ﬁlter papers was
ampliﬁed by multipledisplacement ampliﬁcation(MDA) (10).
TheMDAreactions wereperformed overnightat31 Cin50ml
of reaction solution containing 37.5 mM Tris–HCl (pH 7.5),
50 mM KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, 1 mM dNTP,
0.05 mM thiophosphate-modiﬁed random hexamer (50-
NNNN
sN
sN), 1–5 ng genomic DNA, 0.2 U yeast pyrophos-
phatase and 1 U Phi29 polymerase. The products of the MDA
reaction were resolved on a 1% agarose gel stained with
ethidium bromide. The yield of ampliﬁed genomic DNA
was between 15 and 20 mgi na5 0ml reaction solution.
MIF DNA fragment amplification by PCR
Oligonucleotide primer sets were designed to amplify regions
within the MIF promoter that corresponded to DNA product
sizes of 119, 123, 127 and 131 bp for the 5-, 6-, 7- and 8-CATT
repeat polymorphisms, respectively (Table 1). An additional
set of primers was used for the  173 G/C SNP and produced
a PCR product size of 129 bp. The PCRs were carried out in
a5 0ml solution containing 1· PCR buffer (AmpliTaq Gold;
Applied Biosystem), 2.5 mM MgCl2, 0.2 mM dNTP, 10 pmol
of each forward and reverse primers, 100 ng of genomic DNA
or MDA-ampliﬁed genomic DNA and 1 U AmpliTaq Gold
DNA polymerase. For the CATT repeat, the PCR program was
as follows: 95 C for 10 min, followed by 40 cycles at 94 C for
30 s, 56 C for 30 s, 72 C for 1 min and ﬁnal extension at 72 C
for 10 min, and for the  173 SNP, the PCR program was 95 C
for 10 min, followed by 40 cycles of 94 C for 30 s, 62 C for
30 s, 72 C for 1 min and ﬁnal extension at 72 C for 10 min.
Oligonucleotide probe synthesis
The oligonucleotide probes were designed based on the gen-
eral approach described previously (11), and with the detailed
sequence information provided in Table 1. For the CATT
repeat, the 4 P1 capture probes have 50-aldehyde groups, 10
deoxyadenosine residues at their 50 ends and 30 bases of
upstream sequence, followed by a different number (from
1 to 4) of the CATT repeat, respectively. The P2 detection
probe contains 4 copies of CATT and 20 bases of downstream
sequence, with a biotin at its 30 end for detection and a phos-
phate group at its 50 end for ligation. The P1 and P2 probes
were synthesized by the Yale Keck Biotechnology Facility
at 40/50 nmol scale and were used without post-synthesis
puriﬁcation. Four complementary, single-stranded artiﬁcial
targets with 5–8 copies of the AATG repeat ﬂanked by
30 bases of the MIF promoter sequences both upstream
and downstream of the repeat motif also were synthesized.
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The MIF CATT repeat polymorphism and the  173 G/C SNP
detection are performed by modifying solid-phase techniques
described previously (11). The P1 capture probes are manually
spotted in a format shown in Figure 1B on hydrazine-
functionalized, thin-ﬁlm biosensor chips (Thermo Electron,
Louisville, CO) using 0.3 mlo f1mM P1 in 0.1 M phosphate
buffer, pH 7.8 and 10% glycerol. After incubation for 2 h at
room temperature in a humid chamber, the chips are washed
with 0.1% SDS at 60 C for 30 min, rinsed with water and
dried. A ligation mixture containing 20 mM Tris–HCl, pH 8.3,
25 mM KCl, 10 mM MgCl2, 0.5 mM NAD, 0.01% Triton X-
100, 5 mg/ml acid-treated casein, 10% formamide and 0.04 U/
ml mutant Ampligase (Lys294Arg of Thermus thermophilus
ligase) is applied to each chip and prewarmed to 60 C.
The synthetic targets or MIF PCR amplicons from patient
samples at a concentration of 100 fmol in 10 ml water are
denatured at 95 C for 3 min in the presence of 100 fmol of
the P2-biotin probe. Afterdenaturation,10 mlofthis solutionis
immediately added to the pre-incubated ligation mixture and
incubated at 60 C for 20 min. A stringent wash with 0.01 M
NaOH at 60 C is applied three times, and this is followed by
brieﬂy rinsing three times with 0.1· standard saline citrate
(SSC) at room temperature. The chips are then incubated at
room temperature for 10 min with 100 ml of an anti-biotin–
IgG–horseradish peroxidase conjugate (Jackson Immuno-
Research Lab; 1:1000 dilution from a 1 mg/ml stock in a
buffer containing 5· SSC and 5 mg/ml acid-treated casein).
After brieﬂy washing three times with 0.1· SSC, 100 mlo fa
tetramethylbenzidineformulationfromBioFX Labisadded to
the chips and incubated for 5 min at room temperature, then
Table 1. Oligonucleotide sequences of capture probe P1, detection probe P2, synthetic targets and PCR primers
CATT repeat
Capture probe P1 P1-CATT-1
50-CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATT
P1-CATT-2
50-CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATT
P1-CATT-3
50-CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATTCATT
P1-CATT-4
50-CHO-AAAAAAAAAACTGCTATGTCATGGCTTATCTTCTTTCACCCATTCATTCATTCATT
Detection probe P2 P2 biotin
50-phosphate-CATTCATTCATTCATTCAGCAGTATTAGTCAATGTC-biotin-30
Synthetic target Target AATG-5
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGGGTGAAAGAAGATAAGCCATG
ACATAGCAG
Target AATG-6
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGGGTGAAAGAAGATAAGC
CATGACATAGCAG
Target AATG-7
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGAATGGGTGAAAGAAGAT
AAGCCATGACATAGCAG
Target AATG-8
GACATTGACTAATACTGCTGAATGAATGAATGAATGAATGAATGAATGAATGGGTGAA
AGAAGATAAGCCATGACATAGCAG
PCR primer and product Forward primer: CTATGTCATGGCTTATCTTC
Reverse primer: TCCACTAATGGTAAACTCGG
PCR products: 119, 123, 127 or 131
CTATGTCATGGCTTATCTTCTTTCACC(CATT)5–
8CAGCAGTATTAGTCAATGTCTCTTGATATGCCTGGCACCTGCTAGATGGTCCCCGAGTTTAC
CATTAGTGGA
SNP 173 G/C
Capture probe P1 P1-G
50-CHO-AAAAAAAAAACCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAACAGG
P1-C
50-CHO-AAAAAAAAAACCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAACAGC
Detection probe P2 P2 biotin
50-phosphate-TTGGAGCGGTGCGCCGGGCTTA-biotin-30
Synthetic target MIF 173 Target G
AGCCCGGCGCACCGCTCCAACCTGTTCTCCACTTGGCGGCTAGAAATCGGCCTGTTCCGG
MIF 173 Target C
AGCCCGGCGCACCGCTCCAAGCTGTTCTCCACTTGGCGGCTAGAAATCGGCCTGTTCCGG
PCR primer and product MIF 173 Forward
ACTAAGAAAGACCCGAGGCG
MIF 173 Reverse
GCAGGACCCTGGGCGACT
PCR product 129 bp
ACTAAGAAAGACCCGAGGCGAGGCCGGAACAGGCCGATTTCTAGCCGCCAAGTGGAGAA
CAGGTTGGAGCGGTGCGCCGGGCTTAGCGGCGGTTGCTGGAGGAACGGGCGGAGTCGCCCAGGGTCCTGC
The underlined sequences designate the unique repeated sequences (5–8 repeats) present in the synthetic oligonucleotide target. The bolded residue designates
the –173 G/C SNP.
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morphisms are scored visually and the results are recorded by
imaging under a dissection microscope ﬁtted with a digital
camera.
RESULTS AND DISCUSSION
Figure 1 illustrates the hybridization and ligation-based
detection strategy of the biosensor methodology used for
detecting the MIF promoter CATT repeat, which is present
in a copy number of 5–8, and the  173 G/C SNP. Of impor-
tance, prior ligation-based assays have been found to be efﬁ-
cient only for discriminating polymorphic alleles of short
microsatellite repeats <30 bases (11,12). Ligation of longer
repeats lacks speciﬁcity because of the looping out of repeat
units in the probe/target hybrids. The loopout often occurs in
an area outside of the ligase footprint that can span 26–30
bases (12). To avoid the formation of loopouts in the MIF
CATT repeat sequence, we divided the repeat into the capture
probes ‘P1’, with CATT 1, 2, 3 or 4, and ‘P2’, with CATT4
(Figure 1A), thereby ensuring that the ligase footprint covers
6–7-CATT repeat units. Four capture probes with 1, 2, 3 and
4 CATT repeat units, respectively, together with 30 bases of
the upstream adjacent unique MIF sequence (see detailed
sequences in Table 1) are covalently arrayed by the reaction
between an aldehyde group at their 50-termini and the hydra-
zine group on the chip surface. A detection probe, P2, with
4 copies of the CATT unit and 20 bases of the downstream
adjacent and unique MIF sequence carries a biotin at the 30 end
for detection and a phosphate at its 50 end for ligation. When
target DNA with a variable number of the CATT unit (from
5 to 8, e.g. the 6-CATT shown in Figure 1A), is hybridized
with the P1 and P2 probes on the chip surface in the presence
of a thermostable DNA ligase, the enzyme selects only
perfectly matched P1+P2/target for ligation. This reaction
results in the immobilization of the biotinylated P2 probe at
the matched P1 probe position on the chip surface. After a
stringent wash to remove all non-ligated molecules, a biotin-
associated detection procedure is applied to generate a color
that can be visualized by the unaided human eye. The biochips
can also be printed by high-throughput ‘spotting’ of the req-
uisite capture probes onto hydrazine-functionalized thin-ﬁlm
biosensor chips. The entire methodology is low in cost and
once printed, the chips are robust and require no instrumenta-
tion for analysis.
Biochip Template
+
5
5
6
6
7
7
8
8
G G C C
7 mm
55/GG 56/GG 56/GC 66/GG 66/GC
57/GC 67/GC 67/CC 77/CC 78/CC
A B
C
Figure 1. (A) Schematic representation for the detection of the MIF CATT tetranucleotide repeat by ligation of biotinylated detection probe P2 to a set of capture
probes P1 with different copies of CATT repeat immobilized on thin-film biosensor chip surface in the presence of certain CATT target (i.e. CATT 6). (B) Array
templateforthe detection ofthe 5-,6-,7-and8-CATTrepeats,andthe  173 G/CSNP.Oligonucleotidesarearrayed in duplicates,asshown.+: positivecontrol,an
aldehyde modified dA20-biotin probe. (C) Visual appearance of the biochip arrays of the representative MIF genotypes.
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repeats of 5, 6, 7 or 8 AATG, we ﬁrst tested the detection
speciﬁcity for the different MIF CATT repeat sequences. A
modiﬁed ligation condition with 10% formamide in the stan-
dard ligation mixture (11) gave unambiguous discrimination
of the CATT repeat copy number. The allele-speciﬁc ligation
strategy was also used for the simultaneous detection of the
MIF SNP G/C  173.
To test for the accuracy of genotyping the CATT repeat
polymorphism and the  173 SNP simultaneously by the
biosensor chip, we analyzed an initial 30 genomic DNA
samples that had been previously studied for MIF genotype.
In our standard methodology, the CATT repeat polymorphism
is detected by capillary electrophoresis of PCR products
ampliﬁed to span the tetranucleotide region, and the
 173 G/C SNP is determined by the ddNTP primer extension
method and capillary electrophoresis, or by pyrosequencing
(6). The typings of the CATT repeat and  173 SNP obtained
by using the biosensor methodology were compared initially
in a blinded fashion. Representative images are shown in
Figure 1C and the optical biosensor genotypes are listed in
Table 2. There was complete concordance of the  173 G/C
SNP genotypes between the two methods. We observed one
discrepancy for a previously analyzed DNA sample bearing
the 8-CATT repeat. The initial chromatographic analysis for
sample 1418 showed that one PCR product peak eluted in an
intermediate position for that expected is either the 7-CATT or
the 8-CATT repeat. The peak was scored as ‘8-CATT’ by the
capillary electrophoresis (5/8), but 7-CATT by the biosensor
chip (5/7). Subsequent reanalysis of this DNA sample by cap-
illary electrophoresis veriﬁed the presence of 7-CATT and the
scoring of this sample as ‘5/7’. The concordance with typing
data for the  173 G/C SNP and the ability to identify errors
in the CATT repeat obtained by capillary electrophoresis
indicate that genotyping by optical biosensor chips is highly
accurate.
As one phase of an ongoing project to study the association
between MIF polymorphisms and severe malarial disease, we
plan to genotype several hundred DNA specimens obtained
in rural ﬁeld settings. Finger stick blood samples are
routinely collected and dried onto ﬁlter papers at local hospi-
tals and stored on-site under ambient conditions. Limited
amounts of genomic DNA are present in these blood-
spotted ﬁlter papers, and a pre-ampliﬁcation step, typically
by MDA technology (10), allows these precious samples to
be used for hundreds of PCRs. To evaluate concordance
between MDA products and unampliﬁed genomic DNA for
the ligation-based optical biosensor methodology, the 30 sam-
ples genotyped in the previous experiment were re-evaluated
after MDA. Complete ﬁdelity was observed between the
unampliﬁed genomic DNA and the MDA products for both
the MIF CATT polymorphism and the  173 G/C SNP geno-
type. It is important to point out that with respect to the appli-
cability of this method to other genes, some sequences may
not be amenable to genotyping if they reside in repeated
Table2.ComparisonofMIFgenotypesoftheCATTtetranucleotiderepeatand
the  173 G/C SNP in a selection of human DNA samples by optical biosensor
chip and capillary electrophoresis
Sample ID CATT repeat  173 G/C SNP
Capillary
electrophoresis
Optical
biosensor
chip
Capillary
electrophoresis
Optical
biosensor
chip
0009 5/6 5/6 G/G G/G
0010 6/6 6/6 G/G G/G
0013 6/6 6/6 G/G G/G
0014 5/5 5/5 G/G G/G
0015 6/7 6/7 C/G C/G
0132 5/5 5/5 G/G G/G
0134 5/5 5/5 G/G G/G
0209 5/6 5/6 G/G G/G
0306 5/6 5/6 G/G G/G
0422 5/6 5/6 G/G G/G
0425 5/7 5/7 G/C G/C
0428 6/6 6/6 G/G G/G
0429 5/7 5/7 G/C G/C
0431 5/6 5/6 G/G G/G
0506 6/6 6/6 G/G G/G
0507 6/7 6/7 C/C C/C
0602 7/7 7/7 C/C C/C
0603 5/6 5/6 G/C G/C
0807 6/7 6/7 G/C G/C
1003 6/6 6/6 G/G G/G
1203 6/6 6/6 G/G G/G
1206 6/6 6/6 G/C G/C
1207 6/6 6/6 G/C G/C
1308 5/6 5/6 G/G G/G
1418
a 5/8
a 5/7
a G/C G/C
1603 6/6 6/6 G/G G/G
1606 5/6 5/6 G/G G/G
0036 7/7 7/7 C/C C/C
0914 7/8 7/8 C/C C/C
1214 6/7 6/7 C/C C/C
Different samples were first typed by biosensor chip methodology, and then
verified by capillary electrophoresis and pyrosequencing.
aA discrepancy reading between optical biosensor chip and capillary
electrophoresis.
Table 3. Allele and genotype frequencies of the MIF polymorphisms in Caucasian and African populations
MIF polymorphism Genotype, frequency no. (%) Allele frequency (%)
CATT(5–8) 5/5 5/6 5/7 6/6 6/7 7/7 5 6 7
Caucasian
a (n ¼ 159) 8 (5.0) 61 (38.3) 10 (6.3) 53 (33.3) 25 (15.7) 0 (0) 27.3 60.3 11.0
Zambia malaria (n ¼ 40) 14 (35.0) 14 (35.0) 3 (7.5) 5 (12.5) 1 (2.5) 3 (7.5) 56.3 31.2 12.5
African control groups (n ¼ 40) 5 (12.5) 19 (47.5) 4 (10.0) 5 (12.5) 7 (17.5) 0 (0) 41.3 45.0 13.7
 173 SNP G/C G/G G/C C/C G C
Caucasian
b (n ¼ 88) 67 (76.1) 21 (23.9) 0 (0) 88.1 11.9
Zambia malaria (n ¼ 40) 12 (30.0) 12 (30.0) 16 (40.0) 45.0 55.0
African control groups (n ¼ 40) 6 (15.0) 19 (47.5) 15 (37.5) 38.7 61.3
aData cited from Baugh et al.(6).
bData cited from Donn et al.(8).
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where in the genome, and additional optimization studies may
be necessary.
The ﬁrst 40 samples from patients in Zambia with
P.falciparum malaria were collected and dried onto ﬁlter
papers, stored at ambient temperature and the genomic
DNA extracted with the QIAamp DNA Blood Mini kit
(Qiagen). DNA yields were reliably 10–20 ng per sample.
Ten nanograms of the isolated, genomic DNA was used for
whole genome ampliﬁcation by MDA in a standard 50 ml
reaction, resulting in 15–20 mg of the MDA product per
reaction. Targets for the MIF polymorphic genotyping were
prepared by PCR of 100 ng of MDA-ampliﬁed products. The
genotyping was performed on optical biosensor chips, and the
genotypes and allele frequencies were compared with that of
a previously reported Caucasian control group (Table 3).
The initial data indicated a possible difference in the allelic
distribution of MIF genotypes in different populations.
In particular among the Zambian samples, there was a relative
increase in the proportion of the low-expression 5-CATT
allele, and a corresponding decrease in the proportion of
the high-expression 6-CATT and 7-CATT alleles when com-
pared with the recent studies in Caucasian populations (6,13).
Furthermore, the SNP analysis revealed a relative decrease in
the  173G and a corresponding increase in the  173C in the
Zambian samples when compared with previously studied
Caucasian groups. We then analyzed small representative
sets of DNA samples obtained from four different
North African tribes and one African-American group. The
allelic distribution, when summed over the different groups,
appeared closer in distribution to the Zambian group than that
5
X
78%
5
X
46%
5
X
62%
5
X
60%
5
X
46%
5
X
65%
Figure 2. Distribution of MIF CATT allele frequencies in different populations superimposed on human migration patterns.
Table 5. Compilation of MIF allele frequencies for the CATT repeat in different population groups determined by both biochip and standard methodologies
5/5 (%) 5/6 (%) 5/7 (%) 5/8 (%) 6/6 (%) 6/7 (%) 6/8 (%) 7/7(%) 5/5 +5/X(%) X/X (%) N
Zambia 52 (27.6) 86 (45.7) 6 (3.2) 2 (1.1) 18 (9.6) 18 (9.6) — 6 (3.2) 146 (77.7) 42 (22.3) 188
N. Africa 3 (8.8) 17 (50) 2 (5.9) — 4 (11.7) 5 (14.7) — 3 (8.8) 22 (64.7) 12 (35.3) 34
NE Asia 18 (18) 31 (31) 13 (13) — 25 (25) 12 (12) — 1 (1) 62 (62) 38 (38.0) 100
Caucasian 37 (6.2) 185 (30.9) 49 (8.2) 1 (0.2) 243 (40.6) 69 (11.5) — 13 (2.1) 272 (45.5) 325 (54.5) 597
African Am. 31 (14.5) 73 (34.2) 22 (10.3) 1 (0.5) 45 (21.4) 35 (16.4) 2 (0.9) 4 (1.9) 127 (59.6) 86 (40.3) 213
N. Africa, North African; NE Asia, Korean; African Am., African-American; X: 6-, 7- or 8-CATT MIF allele.
Table 4. Association between parasitemia level on admission and MIF
genotype for children evaluated at the Macha Mission Hospital in Zambia
Parasitemia MIF genotype (n,% )
5/X X/X P-value
<10000 27 (84.4) 5 (71.4) 0.04
>10000 5 (15.6) 2 (28.6)
8-CATT MIF alleles.
5 ¼ low-expression 5-CATT MIF allele; X ¼ higher expression 6-, 7- or
e121 Nucleic Acids Research, 2005, Vol. 33, No. 13 PAGE 6 OF 8described previously in Caucasian groups (included in
Table 3) (6,13).
With respect to clinical malaria infection, the small number
of samples from Zambia did not permit us to make any mean-
ingful determinations with respect to MIF alleles and disease
complications or severity. Nevertheless, logistic regression
analysis revealed that patients with the 5/X genotype
(where X ¼ 6-, 7- or 8-CATT allele) were signiﬁcantly less
likely to have parasitemia >10000 than those with an X/X
genotype (P ¼ 0.04) (Table 4). Whether this ﬁnding indeed
signiﬁes a protective effect of low-expression MIF alleles is
yet to be conﬁrmed by larger studies. Such an association
could provide prognostic information and inﬂuence treatment
options, which frequently necessitates blood transfusions that
are costly and may carry risk of HIV or hepatitis infection.
The data suggesting ethnic variation in the allelic frequency
of the functional MIF CATT promoter polymorphism
prompted us to study additional samples, including a set of
100 control (disease-free) specimens obtained from Korea.
This analysis showed an allelic distribution that was interme-
diate in 5-CATT (62%, 5/5 or 5/X) and non-5-CATT (38%,
X/X)frequencywhencomparedwiththeAfrican orpreviously
analyzed Caucasian groups (6,13), and is in agreement
with the proportions reported in a recent study of a Japanese
population (14).
Table 5 summarizes the data that we obtained for the
frequency of the MIF alleles in different populations around
the world. By a conservative test, none of the populations
with sample size >100 deviated signiﬁcantly from Hardy–
Weinberg ratios for the CATT polymorphism. Additional
studies are necessary to determine if this distribution in
CATT repeats reﬂect the relatedness between populations,
as may be suggested by the representation in Figure 2. Ethnic
variations in the distribution of different MIF alleles is an
important ﬁnding, given the emerging association between
these alleles and different inﬂammatory and infectious
diseases (5–9,13,14). Racial or geographic variations in the
population distribution of MIF alleles also suggest the possi-
bility of different selective pressures acting on the MIF locus.
Given the high prevalence of low-expression MIF alleles
in Africa, these pressures could include historical exposure
to tropical infections such as malaria,in which MIF is believed
to play an important pathogenic role (15–17).
In conclusion, the robust optical biosensor methodology
described herein has high ﬁdelity when compared with the
currently used methods and instrumentation, and it can be
readily combined with the MDA technique to analyze minute
quantities of DNA extracted from dried, whole blood speci-
mens. This method will greatly facilitate the genotyping and
population studies in different ﬁeld settings, and it makes
possible the rapid translation of genotyping information in
the clinic into medical intervention.
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